STOCK TITAN

3D Systems Corp. - DDD STOCK NEWS

Welcome to our dedicated news page for 3D Systems (Ticker: DDD), a resource for investors and traders seeking the latest updates and insights on 3D Systems.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect 3D Systems's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of 3D Systems's position in the market.

Rhea-AI Summary
3D Systems Corporation (NYSE:DDD) reported financial results for Q4 and full year 2023, showing revenue declines due to softness in dental orthodontics and depressed printer sales. The company's net loss increased significantly, driven by impairment charges. Despite challenges, 3D Systems aims to improve margins, reduce costs, and focus on key growth investments in Healthcare and Industrial Solutions.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
earnings
-
Rhea-AI Summary
3D Systems introduces a groundbreaking solution for jetted, monolithic dentures using unique materials for teeth and gums, offering superior aesthetics, durability, and break resistance. Glidewell, the world's largest dental lab, plans to implement this innovative denture solution in 2024. The global denture market is estimated to exceed $2 billion by 2028.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.75%
Tags
none
-
Rhea-AI Summary
3D Systems (DDD) will announce its Q4 and full-year 2023 financial results on February 27, 2024, followed by a conference call on February 28, 2024. Investors can listen via webcast or participate by phone.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
5.7%
Tags
earnings
Rhea-AI Summary
3D Systems' subsidiary, Systemic Bio™, has had two abstracts accepted for presentation at the SOT 2024 Annual Meeting and the AACR 2024 Annual Meeting. The abstracts showcase advanced liver models that offer significant improvements in assessing Drug-Induced Liver Injury (DILI) and Drug Metabolism and Pharmacokinetics (DMPK), as well as a novel model for evaluating cancer treatments and their impacts on the liver. The presentations will be made by Systemic Bio's team members at the respective conferences.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.52%
Tags
conferences
-
Rhea-AI Summary
3D Systems (NYSE:DDD) announced that WeAreAM, a digital and metal additive manufacturing company located in Brescia, Lombardia, Italy, has added 3D Systems’ DMP Flex 350 Dual to its new Center of Excellence. This direct metal printing solution will enable WeAreAM to explore an expanded set of applications, thus helping accelerate innovation. The addition of this printer will not only help WeAreAM address its customers’ evolving application needs and catalyze innovation, it will also help improve productivity. Additionally, 3D Systems’ newest partner in Italy, Gruppo Grazioli, will work in close collaboration with WeAreAM providing training, support, and other services to ensure manufacturers integrating AM are maximizing the solution and thus their investment.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.17%
Tags
none
-
Rhea-AI Summary
3D Systems (DDD) announces changes in leadership structure, with Reji Puthenveetil taking on expanded responsibilities as EVP, Additive Solutions and Chief Commercial Officer. Menno Ellis and Andy Johnson will be leaving the company. The company will continue to operate two business units, Healthcare Solutions, and Industrial Solutions.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.12%
Tags
management
Rhea-AI Summary
3D Systems (DDD) announced its participation in the 26th Annual Needham Growth Conference on January 17, 2024. President and CEO, Dr. Jeffrey Graves, will join a fireside chat and participate in individual meetings with the company’s leadership team. A live webcast of the conference presentation will be available on 3D Systems’ Investor Relations page, with on-demand viewing available 24 hours after the event.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.52%
Tags
conferences
-
Rhea-AI Summary
3D Systems (NYSE:DDD) announced the addition of Jeffrey Creech as Executive Vice President and Chief Financial Officer, and Harriss Currie as President - Regenerative Medicine. The new organization structure reflects the company's focus on regenerative medicine technologies and potential value creation. Creech brings over 25 years of financial leadership experience, while Currie has 30 years of executive leadership experience in building emerging businesses.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
5.94%
Tags
none
-
Rhea-AI Summary
3D Systems (NYSE:DDD) announced the repurchase of approximately $135 million of its 0% coupon, convertible senior notes at a 26% discount to par value. The principal balance has been reduced from $460 million to approximately $325 million, due in 2026. This move reinforces the company's balance sheet strength and maintains a strong cash position to support operational needs and strategic investments.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
7.04%
Tags
buyback
Rhea-AI Summary
3D Systems (NYSE:DDD) announces FDA clearance for NextDent Base, a third-generation material for printing removable dentures. The material offers high break resistance, accurate printing, and repeatable results. It is part of the company’s portfolio of 30 unique NextDent resins. The denture market is anticipated to reach more than $2 billion by 2028.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.99%
Tags
clinical trial
3D Systems Corp.

NYSE:DDD

DDD Rankings

DDD Stock Data

697.86M
129.14M
2.64%
66.05%
7.03%
Computer Storage Device Manufacturing
Manufacturing
Link
US
Rock Hill

About DDD

3d systems provides the most advanced and comprehensive 3d digital design and fabrication solutions available today, including 3d printers, print materials and cloud-sourced custom parts. its powerful ecosystem transforms entire industries by empowering professionals and consumers everywhere to bring their ideas to life using its vast material selection, including plastics, metals, ceramics and edibles. 3ds’ leading personalized medicine capabilities save lives and include end-to-end simulation, training and planning, and printing of surgical instruments and devices for personalized surgery and patient specific medical and dental devices. its democratized 3d digital design, fabrication and inspection products provide seamless interoperability and incorporate the latest immersive computing technologies. 3ds’ products and services disrupt traditional methods, deliver improved results and empower its customers to manufacture the future now.